Enlivex Therapeutics Ltd. (TLV:ENLV)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
395.80
+3.10 (0.79%)
Jul 9, 2025, 5:24 PM IDT

Enlivex Therapeutics Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
9494181255356390
Upgrade
Market Cap Growth
-67.17%-48.18%-29.06%-28.46%-8.65%30.23%
Upgrade
Enterprise Value
2778771102302
Upgrade
Last Close Price
3.934.139.7213.4417.9028.40
Upgrade
PB Ratio
1.221.091.671.271.353.42
Upgrade
P/TBV Ratio
1.221.091.671.271.353.42
Upgrade
Debt / Equity Ratio
0.020.020.030.090.070.02
Upgrade
Quick Ratio
6.966.564.557.7018.098.17
Upgrade
Current Ratio
7.206.845.577.9218.328.72
Upgrade
Return on Equity (ROE)
-60.35%-55.95%-66.88%-43.78%-24.01%-50.56%
Upgrade
Return on Assets (ROA)
-34.24%-30.10%-30.09%-19.81%-17.79%-21.12%
Upgrade
Return on Capital (ROIC)
-38.57%-35.16%-33.88%-21.11%-18.95%-25.54%
Upgrade
Earnings Yield
-56.85%-58.36%-57.89%-42.84%-12.63%-9.74%
Upgrade
FCF Yield
-52.44%-50.96%-47.31%-44.24%-16.73%-9.91%
Upgrade
Buyback Yield / Dilution
-16.88%-10.44%-0.98%-3.00%-35.62%-52.25%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.